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Abstract
Background:  Heart failure is a major and growing public health problem worldwide. The
prognosis of Heart Failure (HF) is uniformly poor despite advances in treatment. The aims of the
present study were to determine the causes of HF among patients admitted to a Nigerian tertiary
medical centre, to determine the prevalence of factors known to be associated with poor prognosis
among these patients, and to compare the factors and causes between males and females.
Methods: The study was cross-sectional in design, carried out on eligible patients who were
consecutively admitted with HF, in Aminu Kano Teaching Hospital, Kano, Nigeria. The following
established factors associated with poor prognosis of HF were assessed: low Left Ventricular
Ejection Fraction (LVEF) of ≤ 40%, anaemia, renal impairment, cardiac rhythm disturbances on the
electrocardiogram, prolonged corrected QT interval (QTc), complete Left Bundle Branch Block
(LBBB) and advanced age.
Results: A total of 79 patients were studied over a six-month period. Forty four (55.7%) of these
patients were males while the remaining 35 (44.3%) were females. The most prevalent prognostic
factor was low LVEF found in a total of 35 patients (44.3%), while the least prevalent was complete
LBBB found in two male patients only (2.53%). The commonest cause of heart failure in all patients
and males was hypertensive heart disease, found in a total of 45 patients (57.0%), comprising of 33
male (73.3%) and 12 female patients (26.7%) (p = 0.0003). Cardiomyopathies were the commonest
causes in females, the predominant type being peripartum cardiomyopathy found in 11 (31.4%)
female patients. Acute myocardial infarction has emerged to be an important cause of HF in males
(13.6%) with a high in-hospital mortality of 66.7%.
Conclusion:  The most prevalent factor associated with poor prognosis was low LVEF.
Hypertensive heart disease and cardiomyopathies were the most common causes of HF in males
and females respectively. The findings of the study should guide decision-making regarding
management of HF patients.
Background
Heart Failure (HF) is a major public health problem
worldwide, affecting approximately 5 million Americans
and 0.4–2% of the general European population.[1,2]
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Though there are no large scale studies on HF in Africa
including Nigeria, previous studies have revealed a hospi-
tal admission rate of 3–7% for HF across the region,
which is similar to the rate in developed countries of
Western Europe and America.[3] Unfortunately, the prog-
nosis of HF is uniformly poor despite advances in treat-
ment. Half of the patients carrying the diagnosis of HF are
likely to die within 4 years, while more than 50% of those
with severe HF are likely to die within one year.[2]
Women with HF differ from men in their demographic
and clinical characteristics, and possibly in their response
to HF treatment.[1] Several studies from the western
world have shown that women with HF have better prog-
nosis.[4] However, women in developing countries are an
economically and socially disadvantaged group, hence
the emphasis on them in the Millennium Development
Goals of the United Nations.[5]
The aims of the present study were to determine the causes
of heart failure among patients admitted to a Nigerian ter-
tiary medical centre, to determine the prevalence of fac-
tors known to be associated with poor prognosis among
these patients, and to compare the factors and causes
between males and females.
Methods
The study was carried out in Aminu Kano Teaching Hos-
pital, which is affiliated to Bayero University, Kano,
Nigeria. It is the only tertiary health centre in the most
populous Nigerian State of Kano, North-Central Nigeria.
It receives referrals from hospitals in Kano and Jigawa
States, as well as from parts of neighbouring States includ-
ing Katsina, Yobe and Bauchi States.
The Research Ethics Committee of Aminu Kano Teaching
Hospital reviewed and approved the study protocol. All
recruited patients gave written informed consent to partic-
ipate in the study. The study conformed to the principles
outlined in the Declaration of Helsinki, on the ethical
principles for medical research involving human sub-
jects.[6]
The study was cross-sectional in design. Eligible patients
were recruited consecutively into the study after obtaining
informed consent. For patients to be eligible, they had to
meet the following criteria: age of at least 15 years or
older, confirmed diagnosis of HF, and admission to the
medical wards of the study centre. All other patients were
excluded from the study. Minimum sample size was 68
patients calculated with a validated formula [7], applying
a precision of 10% and prevalence of HF of 10%. This
prevalence of HF was estimated from the admission
records of previous 6 months of the medical wards. All
recruited patients were either evaluated immediately after
admission or within the first 48 hours. Detailed history
was taken from all patients and comprehensive physical
examination carried out. The patients were investigated
according to the recommendations of standard guidelines
for the management of patients with HF [1,2]. Other
investigations (e.g. blood cultures) were also carried out
when indicated. Echocardiography was performed by the
authors, according to the recommendations of the Ameri-
can Society of Echocardiography.[8]
Heart failure was defined according to the recommenda-
tions of the European Society of Cardiology.[2] The fol-
lowing established prognostic factors for heart failure
were assessed:[1,2] Left Ventricular Ejection Fraction
(LVEF) of ≤ 40%, anaemia, renal impairment, cardiac
rhythm disturbances, prolonged corrected QT interval
(QTc), complete Left Bundle Branch Block (LBBB) and
advanced age.
Anaemia was defined as Packed Cell Volume of <39% and
<36% in men and women respectively. Renal impairment
was defined as serum creatinine of >176 μmol/l (>2 mg/
dl). Prolonged QTc  on Electrocardiogram (ECG) was
defined as a value >440 ms and >460 ms in males and
females respectively, or more than 500 ms if there was
ventricular depolarization abnormality.[9] Cardiac
rhythm disturbances and complete LBBB were also
defined according standard guidelines.[9] Advanced age
was defined as age of ≥ 65 years.
In patients with systemic hypertension, the diagnosis of
hypertensive heart disease was based on the presence of
any abnormality that is causally related to hypertension
and without alternative explanation, on the ECG and
echocardiogram. These abnormalities include concentric
or eccentric Left Ventricular Hypertrophy (LVH),
increased left ventricular mass index, increased left ven-
tricular or left atrial size and volumes, and diastolic or
systolic left ventricular dysfunctions.[10] Ischemic heart
disease was diagnosed if the subject had either positive
history of typical angina or acute myocardial infarction,
and/or typical ECG abnormalities of acute myocardial inf-
arction or myocardial ischemia, plus ventricular regional
wall motion abnormality on 2D echocardiography.[11]
Wall Motion Score Index was calculated for each patient
with regional wall motion abnormality, and their left ven-
tricular systolic and diastolic functions were evalu-
ated.[12,13] Acute myocardial infarction was defined
according to the recommendations of the joint European
Society of Cardiology/American College of Cardiology
Committee.[14] Rheumatic mitral regurgitation and aor-
tic regurgitation were defined by the presence of valvular
regurgitation in two planes on Doppler echocardiography
and with the following features on 2D echocardiography:
thickened and retracted leaflets and subvalvar apparatus,
restricted leaflet mobility, and poor coaptation of the leaf-BMC Cardiovascular Disorders 2008, 8:16 http://www.biomedcentral.com/1471-2261/8/16
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lets in systole which could be worsened by the dilatation
of the valve annulus.[15,16] Rheumatic mitral stenosis
was defined by the presence of thickened and/or calcified
mitral leaflets and subvalvar apparatus, decreased E-F
slope (on M- Mode echocardiography), 'hockey-stick'
appearance of the anterior mitral leaflet in diastole,
immobility of the posterior mitral leaflet, and narrowed
'fish-mouth' orifice of the mitral valve in the short-axis
view measurable with planimetry (with valve area of ≤ 2.0
cm2) or Doppler echocardiographic techniques (the
diastolic pressure half-time method or the continuity
equation).[15,16] Rheumatic aortic stenosis was defined
by the presence of thickened or calcified and immobile
aortic valve cusps, with commissural fusion causing a nar-
rowed orifice (valve area of ≤ 1.5 cm2), and almost invar-
iably occurring with rheumatic mitral valve
disease.[15,16] Dilated cardiomyopathy was defined by
the presence of dilated left ventricle (with or without dil-
atation of the other 3 cardiac chambers) with global systo-
lic and diastolic dysfunctions.[17] Peripartum
cardiomyopathy was diagnosed if echocardiography had
revealed features of dilated cardiomyopathy (mentioned
above) in the absence of a demonstrable cause or other
structural heart disease, and if disease was identified for
the first time within the last trimester of pregnancy or in
the first 5 months postpartum.[18]
Data analysis was done using SPSS version 16.0. Means
and standard deviations were computed for quantitative
variables and the Student's t-test was used to compare
means. The Chi-squared or Fisher's exact tests were used
to test for significance among categorical variables. A p-
value of < 0.05 was considered significant.
Results
A total of 79 patients were admitted to the medical wards
of Aminu Kano Teaching Hospital with a clinical diagno-
sis of HF over a six-month period (May – October 2007),
and all of them consented to participate in the study. Forty
four (55.7%) of these patients were males while the
remaining 35 (44.3%) were females, giving a male:female
ratio of 1.26:1. The mean age of all the patients was 46.90
± 17.89 years. Though males had higher mean age (49.09
± 16.39 years) compared to females (44.14 ± 19.53 years),
the difference was not statistically significant (p = 0.224).
Table 1 shows factors associated with poor prognosis
among the studied patients and compares males with
females. All the studied patients had at least one such
prognostic factor. The most prevalent prognostic factor
was LVEF ≤ 40 found in 44.3% of all patients, while the
least prevalent was complete LBBB found in two male
patients only (2.5%). Prolonged QTc was significantly
more prevalent in males (p = 0.0037). Atrial Fibrillation
(AF) was the most prevalent rhythm abnormality
recorded from 15 patients (19.0%), comprising of 8 male
(18.2%) and 7 female patients (20.0%) (p = 0.838). Pre-
mature ventricular complexes were recorded from 7
patients (8.9%), comprising of 3 male and 4 female
patients (p = 0.474). Furthermore, atrial flutter and com-
plete Right Bundle Branch Block (RBBB) were absent
among females but recorded from 2 (4.6%) and 7
(15.9%) male patients respectively.
Table 2 describes the aetiologies of heart failure, while
Table 3 describes distribution of the prognostic factors
among patients grouped by heart failure aetiology. These
Tables show that the most common aetiology of HF was
hypertensive heart disease found in a total of 45 patients
(57.0%), comprising of 33 male (73.3%) and 12 female
patients (26.7%) (p = 0.0003). Sixteen patients (35.6%)
with hypertensive heart disease had LVEF ≤ 40%, while 18
of them (40.0%) had anaemia. One-fifth of them (20.0%)
were found to have atrial fibrillation and impaired renal
function.
Cardiomyopathies were the commonest causes of heart
failure among females, affecting 13 of them (37.1%). On
its own, peripartum cardiomyopathy was the 2nd most
common cause of heart failure among all female patients
(31.4%) as well as among all patients (13.9%) in the
series (see Table 2). Patients with peripartum cardiomy-
Table 1: Prognostic factors for heart failure among studied subjects
Factors All patients  Males Females  p-value
N = 79  N = 44 N = 35
LVEF ≤ 40% 35(44.3%) 20(45.5%) 15(42.9%) 0.817
Anaemia 32(40.5%) 21(47.7%) 11(31.4%) 0.143
Abnormal rhythm 24(30.4%) 13(29.6%) 11(31.4%) 0.857
Prolonged QTc 22(27.9%) 18(40.9%) 4(11.4%) 0.004*
Advanced age 16(20.3%) 7(15.9%) 9(25.7%) 0.399
Renal impairment 9(11.4%) 7(15.9%) 2(5.7%) 0.157
Complete LBBB 2(2.5%) 2(4.6%) 0(0%) __
Key: N, Number of patients; LVEF, Left Ventricular Ejection Fraction; LBBB, Left Bundle Branch Block. * p-value statistically significant. Values are 
presented as N with percentages in parenthesis.BMC Cardiovascular Disorders 2008, 8:16 http://www.biomedcentral.com/1471-2261/8/16
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opathy were significantly younger than other female
patients with heart failure; mean age of 26.4 ± 5.7 Vs 52.3
± 18.1 years (p < 0.001). They also had lower parity com-
pared to the other female patients; 3.2 ± 3.1 Vs 5.5 ± 4.0
(p = 0.116). In addition, 9 of them (81.8%) had LVEF ≤
40% while 4 of them (36.4%) had anaemia. The mean
systolic and diastolic blood pressures of these patients
were 106.4 ± 13.6 and 70.0 ± 13.4 mmHg respectively.
None of these patients was known to be hypertensive. Fur-
thermore, six of the patients with peripartum cardiomy-
opathy (54.6%) had LV thrombus, and 4 of these patients
developed cardioembolic stroke events.
Rheumatic heart disease was found in a total of 10
patients (12.7%), six of whom (60.0%) had multi-valvu-
lar disease. The most frequent valvular lesion was rheu-
matic mitral regurgitation affecting 8 patients (10.1%)
comprising of 2 male and 6 female patients (p = 0.065).
In the patients with rheumatic heart disease, 20.0% had
LVEF ≤ 40%, 40% had atrial fibrillation while another
20% had atrial flutter.
Pericardial disease was the cause of heart failure in 10
patients (12.7%). Two of these patients (10.0%) had con-
strictive pericarditis, while the rest had either effusive peri-
carditis or effusive myopericarditis. Four of the patients
(40.0%) had both tuberculosis and acquired immunode-
ficiency syndrome, while five of them (50.0%) gave his-
tory of systemic hypertension. Five of these patients
(50.0%) had advanced age, 40% had anaemia, and 30%
had prolonged QTc while 20% had rhythm disorders.
Acute myocardial infarction was the cause of heart failure
in 6 male patients (13.6% of all males). All of them had
LVEF ≤ 40% and were hypertensive. Anaemia, rhythm dis-
orders and prolonged QTc were found in one-third of
them (see Table 3).
Eight of the studied patients died during the hospitalisa-
tion giving an in-hospital mortality rate of 10.1%. All the
patients who died had LVEF ≤ 40. There was tendency of
higher hospital mortality among males (6 patients,
13.6%) compared to females (2 patients, 5.7%) but this
was not statistically significant (p = 0.246). The mortality
was highest among patients with acute Myocardial Infarc-
tion (4 patients; 66.7%), followed by patients with rheu-
matic heart disease (2 patients; 20.0%) and hypertensive
heart disease (2 patients; 4.4%).
Discussion
This study has assessed the causes of HF among patients
consecutively admitted with HF to a Nigerian tertiary
medical centre. It has also assessed the prevalence of fac-
tors known to be associated with poor prognosis, and has
Table 2: Aetiology of heart failure among studied subjects
Aetiology All patients  Males  Females  p-value
N = 79 N = 44 N = 35
Hypertensive heart disease 45(57.0%) 33(75.0%) 12(34.3%) <0.001*
Peripartum cardiomyopathy 11(13.9%) __ 11(31.4%) __
Rheumatic heart disease 10(12.7%) 6(13.6%) 4(11.4%) 0.769
Pericardial disease 10(12.7%) 5(11.4%) 5(14.2%) 0.698
Dilated cardiomyopathy 8(10.1%) 6(13.6%) 2(5.7%) 0.246
Acute myocardial infarction 6(7.6%) 6(13.6%) 0(0%) __
Cor-pulmonale 2(2.5%) 0(0%) 2(5.7%) __
Key: N, Number of patients; * p-value statistically significant. Values are presented as N with percentages in parenthesis.
Table 3: Distribution of prognostic factors among heart failure patients grouped by aetiology
Factors Hypertensive heart 
disease
Peripartum 
cardiomyopathy
Dilated 
cardiomyopathy
Rheumatic heart 
disease
Acute myocardial 
infarction
N = 45 N = 11 N = 8 N = 10 N = 6
LVEF ≤ 40% 16(35.6%) 9(81.8%) 6(75.0%) 2(20.0%) 6(100.0%)
Anaemia 18(40.0%) 4(36.4%) 4(50.0%) 0 2(33.3%)
Abnormal rhythm 11(24.4%) 0 0 6(60.0%) 2(33.3%)
Prolonged QTc 11(24.4%) 2(18.2%) 4(50.0%) 0 2(33.3%)
Advanced age 9(20.0%) 0 0 0 2(33.3%)
Renal impairment 9(20.0%) 0 0 0 0
Complete LBBB 2(8.9%) 0 0 0 0
Key: N, Number of patients; LVEF, Left Ventricular Ejection Fraction; LBBB, Left Bundle Branch Block. * p-value statistically significant. Values are 
presented as N with percentages in parenthesis.BMC Cardiovascular Disorders 2008, 8:16 http://www.biomedcentral.com/1471-2261/8/16
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compared the factors and aetiologies between males and
females.
The patients in this study were relatively young with a
mean age of 46.90 ± 17.89 years. This finding is similar to
that of a study carried out in Accra (Ghana) on patients
consecutively admitted with HF (mean age of 42.3 ± 0.9
years).[19] Our finding is in contrast to what was reported
from the United States of America (USA) (61 ± 18 years)
and Europe (71.3 ± 12.7 years) on the mean ages of
patients hospitalised for HF.[20,21] It is known that in
non-Western countries, cardiovascular diseases including
HF tend to occur a decade or two earlier than they do in
Western countries; nearly half occur before 70 years of
age, whereas only one fifth occur so early in the West – a
difference attributable to both the earlier occurrence of
cardiovascular events and the lower level of clinical care
available.[22]
In the present study, the prevalence rates of several of fac-
tors associated with poor prognosis were high with few
gender differences, mainly in the prevalence of complete
LBBB recorded from 2 male patients and prolonged QTc
(higher in males) (p = 0.004). The finding of Complete
LBBB and RBBB exclusively among male patients might
have contributed to their higher prevalence of prolonged
QTc. Moreover, hypertensive heart disease was more prev-
alent among males (p = 0.0003). This disorder was found
to be associated with high prevalence of LVH in Kano,[23]
and cardiac hypertrophy is a factor that independently
prolongs QTc.[24]
Low LVEF (≤ 40%) was recorded from 44.3% of all
patients in our series. The prevalence was slightly higher
in males (45.5%) compared to females (42.9%), but the
difference was not statistically significant (p = 0.668). It is
possible that a larger sample size might demonstrate a sig-
nificant statistical difference between the sexes. In fact, a
large study carried out across Europe on patients hospital-
ized with HF had shown a significantly higher prevalence
rate of low LVEF (≤ 40%) in males (47%) compared to
females (24%) (p < 0.001).[21] This appears to be the gen-
eral trend in developed countries.[4] Gender-related dif-
ferences in geometric remodelling and earlier onset of
impaired LV systolic function in males have been
described in animal models, and in humans with aortic
valve stenosis and systemic hypertension.[25]
In the present study, anaemia was found in a total of
40.5% of all patients, and in almost half of male (47.7%)
and one-third of female (31.4%) patients respectively (p =
0.143). This finding is similar to what Olubodun previ-
ously reported (36.7%) from South-Western Nigeria
among patients with hypertensive heart failure.[26] Our
finding was however higher than that of Oyoo and Ogola
(13.2%) reporting from Nairobi (Kenya),[27] but lower
than that of Howie-Esquivel and Dracup (50%) reporting
from Northern California (USA) [20]. Several factors are
known to be associated with low haematoctrit and anae-
mia among HF patients, including sex and age (older
women), race (Caucasians), preserved LV systolic func-
tion and high serum creatinine.[28]
Atrial Fibrillation (AF) was the most prevalent rhythm
abnormality recorded from 15 patients (19.0%), compris-
ing of 8 (53.3%) male and 7 female (20%) patients (p =
0.838). The prevalence of AF is similar to that reported by
Familoni et al (20.7%) among HF patients in Shagamu
(South-Western Nigeria).[29] There are conflicting data
from the industrialized countries regarding gender pre-
ponderance of AF; some studies showing higher preva-
lence of AF among males with HF [4], while others show
female preponderance [21].
The commonest aetiology of HF among all patients and
both sexes in our series was hypertensive heart disease.
This finding is similar to that of other studies in
Nigeria.[29,30] In comparison, the prevalence of hyper-
tensive heart disease was significantly higher in males
with HF compared to females (p < 0.0001). This is proba-
bly a reflection of the higher prevalence of systemic hyper-
tension (defined using systolic/diastolic blood pressure
cut-offs of ≥ 160/90 mmHg respectively), among males
(23.8%) compared to females (17.7%) in the general
population of Kano, according to the 1997 report of Nige-
rian Non-Communicable Diseases Committee.[31] The
present study has described the profile of prognostic fac-
tors for HF secondary to hypertensive heart disease. All the
studied prognostic factors were found in the patients with
this disease, and six out of the seven factors was found in
at least 20% of the patients. History of hypertension and
its cardiac complications were also detected in some
patients with other aetiologies including acute myocardial
infarction and pericardial disease. Hypertensive heart dis-
ease was also one of the three causes of in-hospital mor-
tality, responsible for 4.4% of all HF deaths. This degree
of morbidity and mortality is not surprising given that a
previous study in the same study centre on patients with
systemic hypertension, had shown that majority of
untreated (68.5%) and treated (75.6%) hypertensives
were at very high risk for cardiovascular events, and that
blood pressure control was achieved in only 14.3% of
those on treatment.[23] The preventive approach to this
problem should therefore aim at early identification and
treatment of hypertension and other cardiovascular risk
factors, and improving blood pressure control.
Cardiomyopathies were the commonest aetiology of heart
failure among females in our series. Peripartum cardiomy-
opathy was the aetiology of HF in almost one-thirdBMC Cardiovascular Disorders 2008, 8:16 http://www.biomedcentral.com/1471-2261/8/16
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(31.4%) of all female patients. This disorder has been rec-
ognized as an important cause of HF in Kano and other
northern Nigerian cities such as Katsina, Zaria and
Sokoto, for more than 30 years.[30,32-34] In the present
study, patients with peripartum cardiomyopathy were
found to be younger (26.4 ± 5.7 Vs 52.3 ± 18.1 years) and
had lower parity (3.2 ± 3.1 Vs 5.5 ± 4.0), compared with
the other female patients. About 82% of them had LVEF ≤
40% while 36% of them had anaemia. Thrombus in the
LV was found in 60% of the patients and 36.4% of them
suffered stroke. In addition, none of them was found to be
hypertensive or gave a history of such during previous
pregnancies or puerperal periods. The behaviour of their
blood pressure on long-term follow up is our future
research interest. Peripartum cardiomyopathy has been
extensively studied in Zaria, a city 120 kilometres from
Kano. Though the language and cultures of the inhabit-
ants of the two cities are similar, the Zaria patients differ
from those in Kano in several respects. In Zaria, the risk
for peripartum cardiomyopathy was increased by older
age and higher parity, and 22% of them developed hyper-
tension during follow up for 2–5 years.[35] Peripartum
cardiomyopathy has also been studied in Sokoto, a city
about 500 kilometres from Kano, and with similar lan-
guage and cultural practices.[34] The disorder was also the
commonest cause of consecutive admissions for heart fail-
ure among females, responsible for 60% of the cases.
About one-third of these Sokoto patients were primipa-
rous, 12.3% of them had intracardiac thrombus and 3.1%
had atrial fibrillation. However, transient hypertension
occurred in 27.7% of them, contrary to our finding but in
support of the Zaria experience. Several of our findings are
in agreement with those of Sliwa et al [36] and Fett et al
[37] who reported from South Africa and Haiti respec-
tively. The studied patients in both studies were all of Afri-
can descent. In these studies, the average parity was 3–4
and at least 20% of the patients were primiparous. History
of hypertension was obtained from only 2 patients (2%)
and 4 patients (4%) among those studied in South Africa
and Haiti respectively. The patients were however older
than our patients. The mean age of the South African
patients was 31.6 ± 6.6 years and 31.8 ± 8.1 years for the
Haitians. From the foregoing, it is clear that peripartum
cardiomyopathy is an important cause of morbidity and
mortality among the indigenous populations of Kano and
other parts of North-Central Nigeria, as well as in some
parts of the developing world. It can also be said that per-
ipartum cardiomyopathy is a heterogeneous disease.
Unfortunately, the aetiology is still unknown but likely to
be multifactorial. Research in this area is hampered by its
rarity in the developed world where funds and support are
concentrated.
About 30 years ago, acute myocardial infarction was
reported to be non-existent among Northern Nigeri-
ans.[33] The pattern has however changed over the years,
across the country. In the present study, acute myocardial
infarction was the aetiology of HF among 7.6% of all
patients, found exclusively among males. A recent study
in South-Western Nigeria among patients admitted with
HF has similarly revealed a new trend; ischemic heart dis-
ease was the aetiology in 8.5% of patients.[29] In our
series, all the affected patients had low LVEF, and at least
one-third of them had advanced age, anaemia, abnormal
rhythm, and prolonged QTc. Unfortunately, facilities for
coronary artery angiography, interventions and surgery
were not available at the study centre or in the North-Cen-
tral part of the country. The interplay of these several fac-
tors was responsible for the high mortality suffered by the
affected patients (66.7%). This in-hospital mortality is
higher than what is obtained in countries with developed
health care systems (15–20%).[38]
Other important causes of HF include rheumatic heart
disease, pericardial disease and cor pulmonale, in agree-
ment with earlier studies in Nigeria and other African
nations.[19,27,29,30]
Eight patients (10.1%) died while on admission compris-
ing of 6 male (13.6%) and 2 female (5.7%) patients, with-
out statistically significant gender difference (p = 0.246).
However, our finding seems to support the widely
reported higher mortality in men with HF compared to
women.[4] A common characteristic of these patients was
low LVEF. It is known that LV systolic dysfunction as
assessed by LVEF is the single most important predictor of
outcome among patients with symptomatic heart muscle
disease.[39] As Sub-Saharan Africa (SSA) is believed to be
undergoing rapid epidemiologic transition, it is expected
that cardiovascular diseases including HF and acute myo-
cardial infarction, will soon become even more important
as causes of morbidity and mortality.[3] Unfortunately,
most of SSA is still not yet ready to tackle the burden of
such diseases, at the risk of serious consequences.
Though the minimum sample size requirement was met,
the most important limitation of this study has become
the sample size. A larger sample size that would describe
a robust prognostic factor profile of the HF patients, as
well as possible significant differences between the groups
is desirable. Unfortunately, the achievement of this desire
is hampered by several factors including lack of adequate
manpower, lack of financial support and frequent indus-
trial actions by various professional groups. It is common
knowledge that the costs of medical services in most
developing countries including Nigeria are fully shoul-
dered by the patients themselves. Sadly, some patients
cannot even afford to pay for the admission or for life-sav-
ing drugs such as frusemide. Other important limitations
include lack of facilities for diagnosis including coronaryBMC Cardiovascular Disorders 2008, 8:16 http://www.biomedcentral.com/1471-2261/8/16
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artery angiography, as mentioned earlier. Despite the lim-
itations, the results of this study would contribute towards
bridging the gap of knowledge on HF in the developing
world, and generate hypotheses for new researches. Fortu-
nately, a large multicentre study on HF is being planned
in Nigeria. It is hoped that this will minimise the prob-
lems of limited manpower and resources encountered at
single centres.
Conclusion
This study has revealed that subjects admitted with HF in
the study centre were relatively young and had several fac-
tors associated with poor prognosis The most prevalent
were anaemia, low LVEF and rhythm disorders; each of
them affected >30% of all patients. The commonest aeti-
ology of HF among all patients and males in our series
was hypertensive heart disease. Peripartum and dilated
cardiomyopathies were the commonest causes of HF
among females. Acute myocardial infarction has emerged
as an important cause of HF among males with relatively
high mortality.
Majority of these prognostic factors and aetiologies are
correctable or avoidable. It is hoped that these findings
would guide appropriate management of such patients,
with the hope of minimizing the mortality rate.
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